US equities
|
SPCX
$168.40
▲+5.94%
NVDA
$237.34
▲+1.45%
MU
$1,066.49
▼-0.78%
TSLA
$378.77
▲+2.21%
MSFT
$525.54
▲+1.55%
SNDK
$1,715.45
▼-0.26%
INTC
$117.22
▼-1.77%
META
$743.24
▲+2.08%
SPCX
$168.40
▲+5.94%
NVDA
$237.34
▲+1.45%
MU
$1,066.49
▼-0.78%
TSLA
$378.77
▲+2.21%
MSFT
$525.54
▲+1.55%
SNDK
$1,715.45
▼-0.26%
INTC
$117.22
▼-1.77%
META
$743.24
▲+2.08%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
QuidelOrtho Corporation - Common Stock
(NQ:
QDEL
)
11.86
+1.09 (+10.12%)
Delayed Quote
Updated: 1:14 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about QuidelOrtho Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
QDEL Stock Slumps On Mixed Wall Street Price Target Revisions After Q4 Report
↗
February 12, 2026
UBS, Citi and JPMorgan revised their price targets on the stock on the heels of the company issuing fresh guidance for fiscal 2026.
Via
Stocktwits
Topics
Artificial Intelligence
QDEL Q4 Deep Dive: Margin Expansion, R&D Pipeline, and Guidance Disappoints
February 12, 2026
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s...
Via
StockStory
Topics
Economy
World Trade
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript
↗
February 11, 2026
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript
Via
The Motley Fool
Topics
World Trade
QuidelOrtho Corp (NASDAQ:QDEL) Beats Q4 Earnings Estimates Despite After-Hours Stock Decline
↗
February 11, 2026
Via
Chartmill
QuidelOrtho Corp (NASDAQ:QDEL) Shows High-Quality Technical Breakout Setup
↗
January 06, 2026
Via
Chartmill
QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations
February 11, 2026
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s...
Via
StockStory
Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow
February 09, 2026
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Wednesday after the bell. Here’s what to expect.
Via
StockStory
Topics
World Trade
3 Volatile Stocks We’re Skeptical Of
February 01, 2026
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...
Via
StockStory
3 Stocks Under $50 Walking a Fine Line
January 29, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...
Via
StockStory
3 Reasons to Sell QDEL and 1 Stock to Buy Instead
January 28, 2026
Since July 2025, QuidelOrtho has been in a holding pattern, posting a small return of 4.6% while floating around $26.60.
Via
StockStory
3 Reasons QDEL is Risky and 1 Stock to Buy Instead
January 27, 2026
QuidelOrtho trades at $27.60 per share and has stayed right on track with the overall market, gaining 5.8% over the last six months. At the same time, the S&P 500 has returned 8.8%.
Via
StockStory
Topics
Stocks
QuidelOrtho (NASDAQ:QDEL) Q3 Earnings: Leading The Medical Devices & Supplies - Imaging, Diagnostics Pack
December 11, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - imaging,...
Via
StockStory
Topics
Artificial Intelligence
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?
↗
December 07, 2025
A newly public real-estate platform is putting up numbers that look far more seasoned than its age.
Via
The Motley Fool
Topics
Regulatory Compliance
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock
↗
December 07, 2025
One fund just made a bold bet on a telecom stock undergoing a big transformation
Via
The Motley Fool
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge
↗
December 07, 2025
This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.
Via
The Motley Fool
Topics
Regulatory Compliance
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
↗
December 07, 2025
A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.
Via
The Motley Fool
1 Russell 2000 Stock with Solid Fundamentals and 2 We Turn Down
December 05, 2025
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...
Via
StockStory
Why QuidelOrtho (QDEL) Stock Is Up Today
December 03, 2025
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 2.6% in the morning session after a director, Joseph D Jr. Wilkins, purchased shares of the company's stock. Wilkins acquired...
Via
StockStory
Topics
Artificial Intelligence
Supply Chain
3 Cash-Burning Stocks Walking a Fine Line
December 01, 2025
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...
Via
StockStory
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Ignore
November 25, 2025
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...
Via
StockStory
Topics
Supply Chain
QuidelOrtho (QDEL) Stock Trades Up, Here Is Why
November 25, 2025
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 4.5% in the afternoon session after its CEO, Brian J. Blaser, purchased 23,500 shares of the company for a total of $501,577.
Via
StockStory
Topics
Artificial Intelligence
Government
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know
November 24, 2025
A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government...
Via
StockStory
Topics
Economy
Government
QuidelOrtho (QDEL) Shares Skyrocket, What You Need To Know
November 21, 2025
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 14.9% in the afternoon session after the company's President and CEO, Brian Blaser, purchased 23,500 shares of company stock....
Via
StockStory
Topics
Artificial Intelligence
Stocks
3 Unprofitable Stocks We Keep Off Our Radar
November 19, 2025
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Via
StockStory
5 Revealing Analyst Questions From QuidelOrtho’s Q3 Earnings Call
November 12, 2025
QuidelOrtho’s third quarter was marked by a positive market reaction, reflecting solid execution despite a year-on-year decline in reported sales. Management attributed the quarter’s underlying...
Via
StockStory
Topics
Earnings
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
November 11, 2025
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...
Via
StockStory
Topics
Artificial Intelligence
Stocks
Why QuidelOrtho (QDEL) Stock Is Down Today
November 06, 2025
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 12.8% in the morning session after it reported disappointing third-quarter financial results and reduced its full-year earnings...
Via
StockStory
QDEL Q3 Deep Dive: Margin Progress and Cost Actions Offset Headwinds in Core Diagnostics
November 06, 2025
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects the full year’s...
Via
StockStory
Topics
World Trade
QuidelOrtho (QDEL) Q3 2025 Earnings Transcript
↗
November 05, 2025
QuidelOrtho (QDEL) Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
Supply Chain
World Trade
QuidelOrtho (NASDAQ:QDEL) Beats Q3 Sales Expectations
November 05, 2025
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects the...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
